Kolosis BIO and MTF Biologics Forge Strategic Partnership to Enter Surgical Incision Market
Kolosis BIO (Kolosis), a leading provider of biologics solutions, and MTF Biologics, a global tissue processor and nonprofit organization, are excited to announce their partnership in the surgical incision market.
Kolosis BIO and MTF Biologics Extend Exclusive Agreement
Kolosis BIO (Kolosis), a leading provider of orthobiologics solutions, and MTF Biologics, a global tissue processor and nonprofit organization, are proud to announce the extension of their successful partnership.
Kolosis BIO Announces Strong 2022 Results
Kolosis BIO, LLC (Kolosis), a pure-play biologics company and an exclusive bone graft partner to MTF Biologics, announced today its 2022 results and 2023 expectations.
Charles Crockett
Area Vice President of Sales
Kolosis BIO Announces the Appointment of Charles Crockett as Area Vice President, East
Kolosis BIO, a privately-held pure-play orthobiologics company, announced today the appointment of Charles Crockett as Area Vice President of Sales, East.
Kolosis BIO Announces the Appointment of Michelle Soleimani-Mafi as Director of Operations
Kolosis BIO, a privately-held pure-play orthobiologics company, announced today the appointment of Michelle Soleimani-Mafi as its Director of Operations.
Brandon Bloembergen
Director of Sales
Ben Christensen
Area Vice President of Sales
Michelle Soleimani-Mafi
Director of Operations
Maxwell Hunter
Chief Operating Officer